Frontier Medicines

📍 South San Francisco, United States🗓 Founded 2018👥 77 employees💰 Last funded Jun 2019
Biotechnology Research🌐 frontiermeds.com
Website LinkedIn
Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. We are deploying our technologies in chemoproteomics, covalent drug discovery, and machine learning to develop a pipeline of groundbreaking medicines against the most important drivers of disease. Our lead program targets both the activated and inactive forms of KRAS G12C, a validated driver in a number of cancers that until recently has been undruggable. Our pipeline embodies our vision of bolding advancing science to defeat disease, starting with cancer.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Frontier Medicines?
Frontier Medicines has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Frontier Medicines last raise funding?
The most recent investment in Frontier Medicines recorded on gritt.io was in June 2019.
When was Frontier Medicines founded?
Frontier Medicines was founded in 2018.
What industry is Frontier Medicines in?
Frontier Medicines operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Frontier Medicines based?
Frontier Medicines is headquartered in South San Francisco, United States.